Zhou, H., Zhu, J., Yang, Y., Yang, W., Zhang, L., Liu, L., . . . Zhao, H. Comparison of zuberitamab plus CHOP versus rituximab plus CHOP for the treatment of drug-naïve patients diagnosed with CD20-positive diffuse large B-cell lymphoma: A phase 3 trial. BMJ Publishing Group.
Chicago Style (17th ed.) CitationZhou, Hui, et al. Comparison of Zuberitamab Plus CHOP Versus Rituximab Plus CHOP for the Treatment of Drug-naïve Patients Diagnosed with CD20-positive Diffuse Large B-cell Lymphoma: A Phase 3 Trial. BMJ Publishing Group.
MLA (9th ed.) CitationZhou, Hui, et al. Comparison of Zuberitamab Plus CHOP Versus Rituximab Plus CHOP for the Treatment of Drug-naïve Patients Diagnosed with CD20-positive Diffuse Large B-cell Lymphoma: A Phase 3 Trial. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.